News & Press Releases
Filter by:
MoCRA- Industry Must Prepare For Mandatory Adverse Event Reporting And Safety Substantiation Now: Expert
January 11, 2023
Mintz Member Joanne Hawana and Associate Jean Krebs were interviewed by CosmeticDesign about legal reform in the U.S. Food and Drug Administration.
Mintz Member Joshua Fox spoke to Forbes about the logistics of Shark Tank and how deal terms develop after filming.
Mintz Advises Bio Client Asimov in $200M Fundraising
January 10, 2023
Mintz advised Asimov in a $200 million fundraising aimed at helping the synthetic biology company scale its tools and services business focused on biologics, cell and gene therapies, and RNA. Mintz Member and seasoned life sciences transactional attorney Joshua Fox led a team that included Associates Kaoru Suzuki and Michael Katz.
Mintz Guides QIAGEN In Its $150 Million Purchase Of Verogen
January 09, 2023
Deal Diary: Orrick, Paul Weiss, Mintz On Ipsen Deal For Albireo
January 9, 2023
Mintz's role acting for biotechnology company Albireo Pharma in its sale to Ipsen was covered in The Deal. The article featured Mintz Members Megan Gates, and John Condon and Associate Garrett Galvin, who led for the firm.
House Speaker Turmoil Flashes Warning Lights For Muni Advocates
January 6, 2023
Mintz's Retail and Consumer Products Practice Co-Chair, Charles Samuels, spoke to The Bond Buyer about potential complications to the public finance agenda resulting from a crisis in Republican House Leadership.
